Literature DB >> 21803704

Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in infective endocarditis successfully treated with combination daptomycin and tigecycline.

M Polidori, A Nuccorini, C Tascini, G Gemignani, R Iapoce, A Leonildi, E Tagliaferri, F Menichetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21803704     DOI： 10.1179/joc.2011.23.4.240

Source DB:  PubMed          Journal:  J Chemother        ISSN： 1120-009X            Impact factor:   1.714


× No keyword cloud information.
  13 in total

1.  Enterococcal endocarditis: can we win the war?

Authors:  Jose M Munita; Cesar A Arias; Barbara E Murray
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 2.  Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci.

Authors:  Jose M Munita; Barbara E Murray; Cesar A Arias
Journal:  Int J Antimicrob Agents       Date:  2014-09-02       Impact factor: 5.283

3.  In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.

Authors:  Janet A Hindler; Annie Wong-Beringer; Carmen L Charlton; Shelley A Miller; Theodoros Kelesidis; Marissa Carvalho; George Sakoulas; Poochit Nonejuie; Joseph Pogliano; Victor Nizet; Romney Humphries
Journal:  Antimicrob Agents Chemother       Date:  2015-05-11       Impact factor: 5.191

4.  Endocarditis caused by resistant enterococcus: an overview.

Authors:  Katherine Reyes; Marcus Zervos
Journal:  Curr Infect Dis Rep       Date:  2013-08       Impact factor: 3.725

5.  Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.

Authors:  Jose M Munita; Nagendra N Mishra; Danya Alvarez; Truc T Tran; Lorena Diaz; Diana Panesso; Jinnethe Reyes; Barbara E Murray; Javier A Adachi; Arnold S Bayer; Cesar A Arias
Journal:  Clin Infect Dis       Date:  2014-08-08       Impact factor: 9.079

6.  What's New in the Treatment of Enterococcal Endocarditis?

Authors:  Masayuki Nigo; Jose M Munita; Cesar A Arias; Barbara E Murray
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

Review 7.  Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance.

Authors:  Nico T Mutters; Volker Mersch-Sundermann; Reinier Mutters; Christian Brandt; Wulf Schneider-Brachert; Uwe Frank
Journal:  Dtsch Arztebl Int       Date:  2013-10-25       Impact factor: 5.594

Review 8.  Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?

Authors:  Ana M Guzman Prieto; Willem van Schaik; Malbert R C Rogers; Teresa M Coque; Fernando Baquero; Jukka Corander; Rob J L Willems
Journal:  Front Microbiol       Date:  2016-05-26       Impact factor: 5.640

9.  A multi-omic analysis of an Enterococcus faecium mutant reveals specific genetic mutations and dramatic changes in mRNA and protein expression.

Authors:  De Chang; Yuanfang Zhu; Li An; Jinwen Liu; Longxiang Su; Yinghua Guo; Zhenhong Chen; Yajuan Wang; Li Wang; Junfeng Wang; Tianzhi Li; Xiangqun Fang; Chengxiang Fang; Ruifu Yang; Changting Liu
Journal:  BMC Microbiol       Date:  2013-12-28       Impact factor: 3.605

10.  Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis.

Authors:  Jennifer A Johnson; Eoin R Feeney; David W Kubiak; G Ralph Corey
Journal:  Open Forum Infect Dis       Date:  2015-10-29       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.